FAKTOR OPTIONSSCHEIN - QUEST DIAGNOSTICS | Delayed Deutsche Boerse AG 20:50:38 25/06/2024 BST | ||
| 4.75 EUR | -17.39% |
|
| Current month | -33.10% | ||
| 1 month | -42.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 25/06/24 | 4.75 | -17.39% |
| 24/06/24 | 5.75 | +12.30% |
| 21/06/24 | 5.12 | +9.40% |
| 20/06/24 | 4.68 | +37.24% |
| 19/06/24 | 3.41 | -20.88% |
Delayed Quote Deutsche Boerse AG
Last update June 25, 2024 at 08:50 pm
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | 
BNP Paribas
|
| WKN | PC15QD |
| ISIN | DE000PC15QD7 |
| Date issued | 07/11/2023 |
| Strike | 139 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 50 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 78.35 € |
|---|---|
| Lowest since issue | 2.56 € |
| Spread | 0.23 € |
| Spread % | 4.77% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
138.3
USD
Average target price
147
USD
Spread / Average Target
+6.29%
- Stock Market
- Certificates
- Certificat
